Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty Drugsmedical mutual - ohio InPen Prior Auth | OpenPayer
    Ask Trek AI about this page
    Currentmedical mutual - ohioPolicy N/A

    InPen Smart Insulin Pen

    Customize your policy alerts

    Sign up for all medical mutual - ohio policy alerts

    Know when medical mutual - ohio releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Recommended prior authorization criteria for coverage of the InPen smart insulin pen system (reusable Bluetooth-enabled pen plus app) for members using compatible U-100 rapid-acting insulins. Applies to payer coverage determinations for Medical Mutual - Ohio.

    Policy Summary
    Payermedical mutual - ohio
    PolicyInPen Smart Insulin Pen
    Policy CodePolicy N/A
    Change TypeAnnual review — no material changes
    Effective DateDec 18, 2025
    Last ReviewDec 18, 2025
    Next Review DateDec 18, 2025
    Key ActionObtain prior authorization for pharmacy benefit coverage and document that the patient meets the specified coverage criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥7minimum patient age requirement
    1 yrinitial approval duration
    Humalog/Novolog/Fiaspcompatible insulins listed
    iOS10+/Android6+minimum device OS

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Recommended Authorization Criteria

    Initial coverage criteria — Diabetes Mellitus

    Covered when ALL of the following are met

    Diabetes Mellitus criteria: A: The patient is 7 years of age or older OR is younger than 7 years of age and will be using InPen with adult supervision; AND B: The patient will be using InPen with Humalog, Novolog, or Fiasp; AND C: The patient will use U-100 insulin only; AND D: The patient has access to a device with the ability to install and use the InPen app (e.g. smartphone, tablet, etc. with iOS 10 or later or Android 6 or later); AND E: The patient is able and willing to visit a healthcare provider regularly and test blood glucose levels as recommended by their provider.

    Coverage is not recommended for circumstances that are not specifically listed in the Recommended Authorization Criteria. Criteria will be updated as new published data are available.

    Use of InPen for indications or circumstances not listed in the Recommended Authorization Criteria is not recommended for approval.

    Prior Authorization & Documentation Requirements

    Prior Authorization

    Prior authorization recommended

    Prior authorization is recommended for pharmacy benefit coverage of InPen; approval is recommended when the member meets the conditions of coverage in the policy's Criteria and Initial/Extended Approval sections.

    Step Therapy

    No step therapy required

    There are no step therapy requirements or specified prior-failure trials required by this policy for InPen.

    Documentation Required

    Company may request supporting documentation

    The Company may request additional documentation to support medical necessity; failure to provide requested records may affect coverage determinations.

    • Documentation that may be requested includes patient records, test results, and provider credentials.
    • Additional information must be made available upon request to support the services provided.
    Denial Risk

    Risk of denial for lack of medical necessity or documentation

    The Company may deny reimbursement when the drug or services are not medically necessary, are investigational or experimental, are not within the member's benefits, or when documentation is not provided upon request.

    • Denial may follow a determination that services were not medically necessary or were investigational/experimental.
    • Denial may follow when requested supporting documentation (e.g., records, test results, provider credentials) is not provided.

    Device Background

    InPen is an FDA-cleared smart insulin pen system that combines a reusable Bluetooth-enabled insulin pen with a mobile application that records injections and recommends dosing based on current blood glucose, recent insulin dosing, and active insulin. The system is compatible with specified U-100 rapid-acting insulin cartridges, allows dosing from 0.5 to 30 units in 0.5-unit increments, and requires a compatible mobile device (e.g., smartphone or tablet) for app functionality. Use requires the patient to be able and willing to perform blood glucose testing, engage in diabetes self-care, and attend regular follow-up with a healthcare provider.

    Key Definitions

    Definition — Reusable Bluetooth-enabled smart insulin pen system with mobile app that records injections and recommends doses
    Device nameInPen (reusable Bluetooth-enabled smart insulin pen system)
    Primary functionRecords insulin injections and recommends doses based on current blood glucose, insulin dose, and active insulin.
    Compatible insulinsLilly Humalog U-100 3 mL, Novo Nordisk Novolog U-100 3 mL, Novo Nordisk Fiasp U-100 3 mL.
    Dose incrementsAllows dialing from 0.5 to 30 units in 0.5-unit increments.
    Intended users / limitationsNot intended for persons unable/unwilling to test BG, maintain diabetes self-care, or visit providers regularly; not recommended for blind/visually impaired without trained sighted assistance.
    App/device requirementRequires compatible mobile device to use the mobile app (smartphone/tablet).

    Initial Approval Criteria

    Initial Approval

    Initial approval duration

    Initial approval: 1 year.

    All initial approvals provided for the duration noted; reauthorization requires response to therapy unless noted otherwise.

    Continuation / Extended Approval

    Extended Approval

    Duration for continuation/extended approval

    Extended approval duration: Extended approval: 1 year.

    Reauthorization requires documentation of response to therapy unless otherwise noted.

    Intended Setting

    Note

    Home use requiring compatible smartphone/tablet

    InPen is intended for home or self-administration and requires the patient to have access to a compatible smartphone or tablet to use the InPen app.

    • App requires a compatible mobile device (e.g., smartphone/tablet) capable of installing and running the InPen app
    Policy Summary
    Payermedical mutual - ohio
    PolicyInPen Smart Insulin Pen
    Policy CodePolicy N/A
    Change TypeAnnual review — no material changes
    Effective DateDec 18, 2025
    Last ReviewDec 18, 2025
    Next Review DateDec 18, 2025
    Key ActionObtain prior authorization for pharmacy benefit coverage and document that the patient meets the specified coverage criteria.
    SourceLink
    On This Page
    Recommended Authorization CriteriaPrior Authorization & Documentation RequirementsDevice BackgroundKey DefinitionsInitial Approval CriteriaContinuation / Extended ApprovalIntended Setting